Navigation Links
Drugs Watchdog Faces A Judicial Review

The NHS drugs watchdog will be facing a judicial review in court for the first time. Eisai and Pfizer have been permitted a legal review// over the health watchdog's refusal to approve drugs to treat Alzheimer's disease.

According to the National Institute for Health and Clinical Excellence (Nice), people who are either in the early or in the later stages of Alzheimer's disease cannot be treated with medicines on the NHS. But Eisai and Pfizer mark such assumptions of Nice as ‘irrational’.

Last year Nice declined an appeal over its pronouncement that sufferers with early or late-stage Alzheimer's should not have access to Aricept (donepezil), Reminyl galantamine) or Exelon (rivastigmine). Ebixa (memantine) can be used in clinical studies for sufferers with moderate to severe conditions of Alzheimer's disease.

Judicial review regarding Aricept has been granted to Eisai, the licence holder of Aricept, and Pfizer, its co-promotion partner. This was announced by the companies. Reminyl and Exelon will also be reviewed. As per the activists, patients in the early stages of Alzheimer's also should have access to these drugs which cost around £2.50 a day.

Neil Hunt, chief executive of the Alzheimer's Society which is also involved in this legal battle feels that denying treatment to people who suffer from this devastating disease in the early stages is cruel and unethical. He also added that their legal team will go on to prove that decision of Nice is fundamentally flawed.
JT
'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: